Information for "Any Cycle The second Trial of Osimertinib as the FirstLine Management of NonSmall Mobile or portable Carcinoma of the lung Holding Activating EGFR Variations within Moving Tumor Genetic LiquidLungOCohort One"
From EECH Central
Basic information
Display title | Any Cycle The second Trial of Osimertinib as the FirstLine Management of NonSmall Mobile or portable Carcinoma of the lung Holding Activating EGFR Variations within Moving Tumor Genetic LiquidLungOCohort One |
Default sort key | Any Cycle The second Trial of Osimertinib as the FirstLine Management of NonSmall Mobile or portable Carcinoma of the lung Holding Activating EGFR Variations within Moving Tumor Genetic LiquidLungOCohort One |
Page length (in bytes) | 3,492 |
Page ID | 1400219 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Baboonthrone6 (Talk | contribs) |
Date of page creation | 09:32, 24 April 2024 |
Latest editor | Baboonthrone6 (Talk | contribs) |
Date of latest edit | 09:32, 24 April 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |